UNVEILING THE MOLECULAR MECHANISMS OF NEUROFIBROMIN-1 REGULATION FOR THERAPEUTIC TARGETING IN NEUROFIBROMATOSIS TYPE 1

Regents Of The University Of California, San Francisco, The

Investigators